Nephrology clinical trials recruiting in California

48 recruiting nephrology trials match in California. Showing 20.

• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Recruiting

  Phase 2 · Akebia Therapeutics · Chula Vista, California

• Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)Recruiting

  N/A · Bodyport Inc. · Victorville, California

• SPYRAL GEMINI Pilot StudyRecruiting

  N/A · Medtronic Vascular · Stanford, California

• Repletion of Ergothioneine in Patients With Kidney FailureRecruiting

  N/A · Stanford University · Palo Alto, California

• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRDRecruiting

  Phase 2 · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · Rochester, Minnesota

• Staged Kidney Transplantation During Combined Heart/Kidney TransplantationRecruiting

  N/A · Cedars-Sinai Medical Center · Los Angeles, California

• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell CarcinomaRecruiting

  Phase 1 / Phase 2 · Oncorena AB · Orange, California

• Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective RegistryRecruiting

  N/A · LifeNet Health · Sylmar, California

• Sit Less, Interact and Move More (SLIMM) 2 StudyRecruiting

  Phase 2 · Srinvasan Beddhu · Stanford, California

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruiting

  Phase 3 · Bayer · Buenos Aires

• Adding Urea to the Final Dialysis FluidRecruiting

  Phase 1 / Phase 2 · University of California, San Francisco · San Francisco, California

• A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal DiseaseRecruiting

  N/A · W.L.Gore & Associates · La Mesa, California

• A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney DiseaseRecruiting

  Phase 1 / Phase 2 · Ingenia Therapeutics INC · Herston, Brisbane

• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Huntington Beach, California

• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortRecruiting

  Phase 1 · AstraZeneca · Glendale, California

• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseRecruiting

  Phase 3 · Alessandro Doria · Stanford, California

• Achieving Chronic Care equiTy by leVeraging the Telehealth EcosystemRecruiting

  N/A · University of California, San Francisco · San Francisco, California

• A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisRecruiting

  Phase 3 · Amgen · Los Angeles, California

• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaRecruiting

  Phase 2 · R1 Therapeutics · Chula Vista, California

• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruiting

  N/A · C. R. Bard · La Jolla, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.